Retinal biomarkers for Alzheimer's disease in the prodromal and preclinical population ‐ The Deep and Frequent Phenotyping study

Abstract

Background: Recent challenges for disease‐modifying therapies for Alzheimer's disease (AD) highlighted the need for biomarkers in the prodromal and preclinical stages. The Deep and Frequent Phenotyping (DFP) study aims to identify biomarkers for use in proof‐of‐concept trials.

The paper